Evidence map›Paper›PMID 36938514›Full record

ArticleClinical pathology (Thousand Oaks, Ventura County, Calif.)

Comparative Performance Evaluation of Personal Protective Measures and Antiviral Agents Against SARS-CoV-2 Variants: A Narrative Review.

Md Anamul Haque, Md Tanbir, Bulbul Ahamed, Md Jamal Hossain, Arpita Roy, Mohammad Shahriar, Mohiuddin Ahmed Bhuiyan, Md Rabiul Islam

Abstract read
In one paragraph

Article in Clinical pathology (Thousand Oaks, Ventura County, Calif.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Md Anamul HaqueDepartment of Pharmacy, University of Asia Pacific, Dhaka, Bangladesh.
Md TanbirDepartment of Pharmacy, University of Asia Pacific, Dhaka, Bangladesh.
Bulbul AhamedDepartment of Pharmacy, University of Asia Pacific, Dhaka, Bangladesh.
Md Jamal HossainDepartment of Pharmacy, State University of Bangladesh, Dhaka, Bangladesh.
Arpita RoyDepartment of Biotechnology, School of Engineering & Technology, Sharda University, Greater Noida, India.
Mohammad ShahriarDepartment of Pharmacy, University of Asia Pacific, Dhaka, Bangladesh.
Mohiuddin Ahmed BhuiyanDepartment of Pharmacy, University of Asia Pacific, Dhaka, Bangladesh.
Md Rabiul IslamDepartment of Pharmacy, University of Asia Pacific, Dhaka, Bangladesh.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Scientists identified SARS-CoV-2 in December 2019 in Wuhan city of China. Soon after its identification, Covid-19 spreads almost everywhere. The World Health Organization (WHO) declared the Covid-19 outbreak as a pandemic on March 11, 2020. Countries are facing multiple waves due to the different variants of the coronavirus. Personal preventive measures, vaccines, and antiviral drugs are the approaches to control Covid-19. However, these approaches are being implemented in different countries at different levels because of the availability of personal protective measures and antiviral agents. The objective of this study was to evaluate the effectiveness of practicing measures to fight the Covid-19 pandemic. Here we searched relevant literature from PubMed and Scopus using the keywords such as personal protective measures, antiviral agents, and vaccine effectiveness. According to the present findings, protective measures were found comparatively less effective. Nevertheless, these measures can be used to limit the spreading of Covid-19. Antiviral agents can reduce the hospitalization rate and are more effective than personal protective measures. The most effective strategy against Covid-19 is early vaccination or multiple vaccination dose. The respective authorities should ensure equal distribution of vaccines, free availability of antiviral drugs, and personal protective measure in poor and developing countries. We recommend more studies to describe the effectiveness of practicing preventive measures and antiviral agents against recent variants of the coronavirus.

Indexed as

antiviral agentsEffectivenesspersonal protective equipmentprotective measuresSARS-CoV-2 variantsvaccines

Identifiers

PMID36938514
PMCPMC10014419

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.